Medtronic Capital Surpluse from 2010 to 2025

MDT Stock  USD 88.08  0.92  1.06%   
Medtronic PLC Capital Surpluse yearly trend continues to be comparatively stable with very little volatility. Capital Surpluse will likely drop to about 21.8 B in 2025. From the period from 2010 to 2025, Medtronic PLC Capital Surpluse quarterly data regression had r-value of (0.97) and coefficient of variation of  13.86. View All Fundamentals
 
Capital Surpluse  
First Reported
2015-01-31
Previous Quarter
24.6 B
Current Value
24.6 B
Quarterly Volatility
5.3 B
 
Yuan Drop
 
Covid
Check Medtronic PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 B, Interest Expense of 868.2 M or Total Revenue of 39.1 B, as well as many indicators such as Price To Sales Ratio of 5.29, Dividend Yield of 0.011 or PTB Ratio of 5.46. Medtronic financial statements analysis is a perfect complement when working with Medtronic PLC Valuation or Volatility modules.
  
Check out the analysis of Medtronic PLC Correlation against competitors.
For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Latest Medtronic PLC's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Medtronic PLC over the last few years. It is Medtronic PLC's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medtronic PLC's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Medtronic Capital Surpluse Regression Statistics

Arithmetic Mean27,983,793,750
Geometric Mean27,726,167,130
Coefficient Of Variation13.86
Mean Deviation3,396,206,250
Median28,127,000,000
Standard Deviation3,879,939,931
Sample Variance15053933.9T
Range10.4B
R-Value(0.97)
Mean Square Error1085288.2T
R-Squared0.93
Slope(787,055,147)
Total Sum of Squares225809008T

Medtronic Capital Surpluse History

202521.8 B
202422.1 B
202224.6 B
202124.6 B
202026.3 B
201926.2 B
201826.5 B

About Medtronic PLC Financial Statements

Medtronic PLC shareholders use historical fundamental indicators, such as Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Medtronic PLC investors may analyze each financial statement separately, they are all interrelated. The changes in Medtronic PLC's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medtronic PLC's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Surpluse22.1 B21.8 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.